Ganciclovir therapy for neonates with congenital cytomegalovirus infection [3]

European Journal of Pediatrics

Volumn 166, Issue 6, 2007, Pages 633-634

  Luck, Suzanne ^a   Sharland, Mike ^b   Griffiths, Paul ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Congenital cytomegalovirus; Ganciclovir; Neonate; Valganciclovir

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR;

CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DRUG USE; HEARING IMPAIRMENT; HUMAN; LETTER; NEWBORN; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; PUBLICATION; REGISTER;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; INFANT, NEWBORN;

EID: 34247333737     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0288-8     Document Type: Letter

References (4)

1. Kimberlin DW, Lin C, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kjell JM, Soong S-J, Whitley RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143:16-25
2. Paediatric formulary committee, BNF for Children (2006) In: London: BMJ Publishing Group, RPS Publishing, and RCPCH Publications
3. Smets K, De Coen K, Dhooge I, Standaert L, Laroche S, Mahieu L, Logghe N, Cossey V, Boudewyns A (2006) Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy. Eur J Pediatr (in press)
4. Valganciclovir in congenital CMV infants. http://www.clinicaltrials. gov/show/NCT00031434, last accessed 10/08/06